Arcturus Therapeutics Holdings Inc.

Public

United StatesHealthcarehttps://arcturusrx.com/

Last Round

Seed

Jun 30, 2026

Total Funding Raised

$8M

Company Overview

Arcturus Therapeutics Holdings Inc. is a biotechnology company that develops mRNA medicines and vaccines for infectious diseases and rare liver and respiratory conditions.

Sector

Healthcare

AI Layer

Non-AI

Keywords

mRNA therapeuticslipid-mediated deliveryrna medicinemRNA vaccineself-amplifying mRNASTARRLUNAR platformbiotech platformdrug delivery technologyvaccine platformrare disease treatmentbiotech licensingclinical-stage biotechdelivery vehicle

Arcturus Therapeutics Holdings Inc. Comps

Public and private peers based on sector, stage, and business model.

Arcturus Therapeutics Holdings Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arcturus Therapeutics Holdings Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 30, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Andrew Sassine

Chief Financial Officer And Board Of Director

Executive Team

Arcturus Therapeutics Holdings Inc. Investors

Notable investors and investment history

Arcturus Therapeutics Holdings Inc. investors
Investor	Rounds
1517 Fund	Seed
Wireframe Ventures	Seed
Climate Capital	Seed
Initialized Capital Management	Seed
Breakthrough Energy Discovery	Seed
Toyota Ventures	Seed
Wireframe Ventures	Seed

View all Investors

Arcturus Therapeutics Holdings Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arcturus Therapeutics Holdings Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersUnited States

Employee Range157

Year Founded2013

Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.